Cargando…

Association of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G Promoter Polymorphism with Risk of Keloid in a Chinese Han Population

BACKGROUND: A keloid is pathological scar caused by aberrant response to skin injuries, characterized by excessive accumulation of histological extracellular matrix, and occurs in genetically susceptible individuals. Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yongjie, Long, Jianhong, Wang, Xiaoyan, Sun, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220586/ https://www.ncbi.nlm.nih.gov/pubmed/25350781 http://dx.doi.org/10.12659/MSM.892397

Ejemplares similares

SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population
por: Xu, Xia, et al.
Publicado: (2016)

The -844 G>A PAI-1 Polymorphism Is Associated with Acute Coronary Syndrome in Mexican Population
por: García-González, Ilian Janet, et al.
Publicado: (2015)

Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population
por: Valdés-Alvarado, Emmanuel, et al.
Publicado: (2019)

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children
por: De la Cruz-Mosso, Ulises, et al.
Publicado: (2012)

PAI-1 -675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study
por: Xu, Kuanfeng, et al.
Publicado: (2013)

Association Between - 675 ID, 4G/5G PAI-1 Gene Polymorphism and Pregnancy Loss: A Systematic Review
por: Adler, Grazyna, et al.
Publicado: (2018)

Association between Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Sepsis: A Meta-Analysis
por: Li, Li, et al.
Publicado: (2013)

Association of Plasminogen Activator Inhibitor-Type 1 (-675 4G/5G) Polymorphism with Pre-Eclampsia: Systematic Review
por: Morgan, Jessie A., et al.
Publicado: (2013)

The −675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis
por: Nie, Wei, et al.
Publicado: (2012)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina
por: Kumar, Sunil, et al.
Publicado: (2021)

Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study
por: Yousuf, Syed Douhath, et al.
Publicado: (2022)

Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
por: Wang, Ziran, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor-1 4G/5G Gene Polymorphism and Coronary Artery Disease in the Chinese Han Population: A Meta-Analysis
por: Li, Yan-yan
Publicado: (2012)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

Relationship between post-SARS osteonecrosis and PAI-1 4G/5G gene polymorphisms
por: Sun, Wei, et al.
Publicado: (2013)

The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis
por: Lorente, Leonardo, et al.
Publicado: (2015)

Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension
por: Wang, Ziran, et al.
Publicado: (2023)

PAI-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis
por: Wang, Shangqian, et al.
Publicado: (2013)

Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis
por: Zhang, Xin, et al.
Publicado: (2020)

The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis
por: Živković, Maja, et al.
Publicado: (2014)

Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients
por: Wang, Baoyan, et al.
Publicado: (2021)

In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time
por: de Lange, Zelda, et al.
Publicado: (2013)

The Effect of PAI-1 4G/5G Polymorphism and Clinical Factors on Coronary Artery Occlusion in Myocardial Infarction
por: Parpugga, Tajinder Kumar, et al.
Publicado: (2015)

Association of Leptin Receptor Gene Polymorphisms with Keloids in the Chinese Han Population
por: Liu, Jing, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma
por: Mossböck, Georg, et al.
Publicado: (2008)

The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough
por: Tang, Rui, et al.
Publicado: (2023)

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism
por: Mairuhu, ATA, et al.
Publicado: (2005)

Expression of the GZMB Gene Polymorphism, SNP rs8192917, in 990 Han Chinese Patients with Postoperative Keloids
por: Wen, Xiulin, et al.
Publicado: (2022)

Circulating Levels of PAI-1 and SERPINE1 4G/4G Polymorphism Are Predictive of Poor Prognosis in HCC Patients Undergoing TACE()
por: Divella, Rosa, et al.
Publicado: (2015)

Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects
por: Al-Hamodi, Zaid H., et al.
Publicado: (2012)

Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower
por: Dayco, John, et al.
Publicado: (2022)

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis
por: XU, XIN, et al.
Publicado: (2012)

The Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma Phenotype
por: Lampalo, Marina, et al.
Publicado: (2018)

Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms
por: Zhang, Xueya, et al.
Publicado: (2020)

Exploring a possible association between the occurrence of the SERPINE1-675 4G/5G (rs1799889) polymorphism and the increased risk of esophageal cancer in the Caucasian population
por: Klimczak-Bitner, Anna Agnieszka, et al.
Publicado: (2021)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

Meta-Analysis of the Association between Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Recurrent Pregnancy Loss
por: Li, Xuejiao, et al.
Publicado: (2015)

FEN1 -69G>A and 4150G>T polymorphisms and cancer risk in Chinese population
por: Gao, Xue-ren, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hbjrh4mtsc2qvmb461dl7ftuif